Showing 1 - 5 results of 5 for search 'Marzia Caproni', query time: 0.02s Refine Results
  1. 1
    Novel Advances in Dermatitis Herpetiformis

    Novel Advances in Dermatitis Herpetiformis by Paolo Fabbri, Antonino Salvatore Calabrò, Takashi Hashimoto, Alessio Fasano, Marzia Caproni

    Published 2012-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Newly Described Clinical and Immunopathological Feature of Dermatitis Herpetiformis

    Newly Described Clinical and Immunopathological Feature of Dermatitis Herpetiformis by Veronica Bonciolini, Diletta Bonciani, Alice Verdelli, Antonietta D'Errico, Emiliano Antiga, Paolo Fabbri, Marzia Caproni

    Published 2012-01-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Stevens-Johnson syndrome/TEN induced by lamotrigine in a patient with a cerebral cavernous malformation: a case report

    Stevens-Johnson syndrome/TEN induced by lamotrigine in a patient with a cerebral cavernous malformation: a case report by Chiara Frattini, Alberto Corrà, Elena Mariotti, Cristina Aimo, Valentina Ruffo, Alessandro Magnatta, Simone Landini, Lavinia Quintarelli, Alice Verdelli, Marzia Caproni

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Bullous pemphigoid and mucous membrane pemphigoid humoral responses differ in reactivity towards BP180 midportion and BP230

    Bullous pemphigoid and mucous membrane pemphigoid humoral responses differ in reactivity towards BP180 midportion and BP230 by Feliciana Mariotti, Anna Pira, Naomi De Luca, Anna Rita Giampetruzzi, Filomena Russo, Amilcare Cerri, Giulia Gasparini, Giulia Gasparini, Emanuele Cozzani, Emanuele Cozzani, Angelo V. Marzano, Angelo V. Marzano, Emiliano Antiga, Marzia Caproni, Pietro Quaglino, Marco Carrozzo, Biagio Didona, Giovanni Di Zenzo

    Published 2024-11-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Comparative effectiveness of tildrakizumab 200 mg versus tildrakizumab 100 mg in psoriatic patients with high disease burden or above 90 kg of body weight: a 16-week multicenter retrospective study – IL PSO (Italian landscape psoriasis)

    Comparative effectiveness of tildrakizumab 200 mg versus tildrakizumab 100 mg in psoriatic patients with high disease burden or above 90 kg of body weight: a 16-week multicenter re... by Luigi Gargiulo, Luciano Ibba, Ruggero Cascio Ingurgio, Piergiorgio Malagoli, Fabrizio Amoruso, Anna Balato, Federico Bardazzi, Pina Brianti, Giovanna Brunasso, Martina Burlando, Anna E. Cagni, Marzia Caproni, Carlo G. Carrera, Andrea Carugno, Francesco Caudullo, Aldo Cuccia, Paolo Dapavo, Eugenia V. Di Brizzi, Valentina Dini, Francesca M. Gaiani, Paolo Gisondi, Claudio Guarneri, Claudia Lasagni, Gaetano Licata, Francesco Loconsole, Angelo V. Marzano, Matteo Megna, Santo R. Mercuri, Maria L. Musumeci, Diego Orsini, Simone Ribero, Valentina Ruffo Di Calabria, Francesca Satolli, Davide Strippoli, Massimo Travaglini, Emanuele Trovato, Marina Venturini, Leonardo Zichichi, Mario Valenti, Antonio Costanzo, Alessandra Narcisi

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: